<VariationArchive VariationID="420018" VariationName="NM_001182.5(ALDH7A1):c.503_506del (p.Ile168fs)" VariationType="Deletion" Accession="VCV000420018" Version="12" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-03-17" DateCreated="2017-04-27" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="406608" VariationID="420018">
      <GeneList>
        <Gene Symbol="ALDH7A1" FullName="aldehyde dehydrogenase 7 family member A1" GeneID="501" HGNC_ID="HGNC:877" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="126541841" stop="126595219" display_start="126541841" display_stop="126595219" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="125877532" stop="125931081" display_start="125877532" display_stop="125931081" Strand="-" />
          </Location>
          <OMIM>107323</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001182.5(ALDH7A1):c.503_506del (p.Ile168fs)</Name>
      <CanonicalSPDI>NC_000005.10:126582861:AAGA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q23.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="126582862" stop="126582865" display_start="126582862" display_stop="126582865" variantLength="4" positionVCF="126582861" referenceAlleleVCF="CAAGA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="125918554" stop="125918557" display_start="125918554" display_stop="125918557" variantLength="4" positionVCF="125918553" referenceAlleleVCF="CAAGA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>I168fs</ProteinChange>
      <ProteinChange>I140fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.126582862_126582865del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.126582862_126582865del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.125918554_125918557del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.125918554_125918557del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008600.2" sequenceAccession="NG_008600" sequenceVersion="2" change="g.17526_17529del">
            <Expression>NG_008600.2:g.17526_17529del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001182.5" sequenceAccession="NM_001182" sequenceVersion="5" change="c.503_506del" MANESelect="true">
            <Expression>NM_001182.5:c.503_506del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001173.2" sequenceAccession="NP_001173" sequenceVersion="2" change="p.Ile168fs">
            <Expression>NP_001173.2:p.Ile168fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001201377.2" sequenceAccession="NM_001201377" sequenceVersion="2" change="c.419_422del">
            <Expression>NM_001201377.2:c.419_422del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001188306.1" sequenceAccession="NP_001188306" sequenceVersion="1" change="p.Ile140fs">
            <Expression>NP_001188306.1:p.Ile140fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001202404.2" sequenceAccession="NM_001202404" sequenceVersion="2" change="c.503_506del">
            <Expression>NM_001202404.2:c.503_506del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001189333.2" sequenceAccession="NP_001189333" sequenceVersion="2" change="p.Ile168fs">
            <Expression>NP_001189333.2:p.Ile168fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001182.4" sequenceAccession="NM_001182" sequenceVersion="4" change="c.503_506del">
            <Expression>NM_001182.4:c.503_506del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16618101" DB="ClinGen" />
        <XRef Type="rs" ID="1064794241" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00002" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001182.5(ALDH7A1):c.503_506del (p.Ile168fs) AND not provided" Accession="RCV000486613" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-02-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001182.5(ALDH7A1):c.503_506del (p.Ile168fs) AND Pyridoxine-dependent epilepsy" Accession="RCV001066514" Version="11">
        <ClassifiedConditionList TraitSetID="6038">
          <ClassifiedCondition DB="MedGen" ID="C1849508">Pyridoxine-dependent epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-06-03" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-03" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2017-04-27" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16491085</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19142996</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20554659</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20814824</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30043187</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6038" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1615" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Pyridoxine-Dependent Seizures</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pyridoxine-dependent epilepsy</ElementValue>
                <XRef ID="Pyridoxine-dependent+epilepsy/6116" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009945" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPILEPSY, EARLY-ONSET, 4, VITAMIN B6-DEPENDENT</ElementValue>
                <XRef Type="MIM" ID="266100" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="107323.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pyridoxine dependency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pyridoxine dependency with seizures</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Vitamin B6-dependent seizures</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ALDH7A1 deficiency</ElementValue>
                <XRef ID="GTR000328761" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">EPEO4</ElementValue>
                <XRef Type="MIM" ID="266100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PDE</ElementValue>
                <XRef Type="MIM" ID="266100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EPD</ElementValue>
                <XRef Type="MIM" ID="266100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000515787" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318883" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500153" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520980" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520979" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551668" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593378" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509482" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520995" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Pyridoxine-Dependent Epilepsy - ALDH7A1</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Pyridoxine-dependent epilepsy â€“ ALDH7A1 (PDE-ALDH7A1) is characterized by seizures not well controlled with anti-seizure medication that are responsive clinically and electrographically to large daily supplements of pyridoxine (vitamin B6). This is true across a phenotypic spectrum that ranges from classic to atypical PDE-ALDH7A1. Intellectual disability is common, particularly in classic PDE-ALDH7A1. Classic PDE-ALDH7A1. Untreated seizures begin within the first weeks to months of life. Dramatic presentations of prolonged seizures and recurrent episodes of status epilepticus are typical; recurrent self-limited events including partial seizures, generalized seizures, atonic seizures, myoclonic events, and infantile spasms also occur. Electrographic seizures can occur without clinical correlates. Atypical PDE-ALDH7A1. Findings in untreated individuals can include late-onset seizures beginning between late infancy and age three years, seizures that initially respond to anti-seizure medication and then become intractable, seizures during early life that do not respond to pyridoxine but are subsequently controlled with pyridoxine several months later, and prolonged seizure-free intervals (=5 months) that occur after discontinuation of pyridoxine.</Attribute>
                <XRef ID="NBK1486" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9298" />
                <XRef ID="9298" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301659</ID>
                <ID Source="BookShelf">NBK1486</ID>
              </Citation>
              <XRef ID="3006" DB="Orphanet" />
              <XRef ID="C1849508" DB="MedGen" />
              <XRef ID="MONDO:0009945" DB="MONDO" />
              <XRef Type="MIM" ID="266100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1103453" SubmissionDate="2019-01-29" DateLastUpdated="2017-04-27" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDX:667110|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000568346" DateUpdated="2017-04-27" DateCreated="2017-04-27" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-02-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.503_506delTCTT pathogenic variant in the ALDH7A1 gene has been reported previously (using the alternative nomenclature of c.419_422delTCTT) in an individual with folinic-acid responsive seizures and elevated pipecolic acid in CSF who also had a second ALDH7A1 variant identified (Nicolai et al., 2006; Gallagher et al., 2009). The deletion causes a frameshift starting with codon Isoleucine 168, changes this amino acid to a Serine residue and creates a premature Stop codon at position 10 of the new reading frame, denoted p.Ile168SerfsX10. This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.503_506delTCTT variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Therefore, the c.503_506delTCTT variant is considered a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALDH7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001182.4:c.503_506delTCTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4987354" SubmissionDate="2022-07-15" DateLastUpdated="2022-07-17" DateCreated="2022-07-17">
        <ClinVarSubmissionID localKey="NM_001182.4:c.503_506delTCTT|MedGen:C1849508" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002548158" DateUpdated="2022-07-17" DateCreated="2022-07-17" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30043187</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19142996</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20554659</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20814824</ID>
          </Citation>
          <Comment>Variant summary: ALDH7A1 c.503_506delTCTT (p.Ile168SerfsX10) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 4e-06 in 251422 control chromosomes. c.503_506delTCTT has been reported in the literature as a compound heterozygous genotype in at-least two individuals affected with Pyridoxine-Dependent Epilepsy (example, Gallagher_2009, Mills_2010) and continues to be subsequently cited by others (example, Coughlin_2019, Scharer_2010). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALDH7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001182.4:c.503_506delTCTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1849508" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11800792</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7576297" SubmissionDate="2023-10-18" DateLastUpdated="2023-10-28" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="NM_001182.5:c.503_506del|OMIM:266100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004049794" DateUpdated="2023-10-28" DateCreated="2023-10-28" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALDH7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001182.5:c.503_506del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="266100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13910671</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3966584" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="17f1fffd3e8e5827c4675250f3f8edd54c05421e52bd62e8f8e7eb19c9626b88|OMIM:266100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002024816" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001182.4:c.503_506del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="266100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2397125" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="478343|MedGen:C1849508" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001231527" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19142996</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16491085</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20554659</ID>
          </Citation>
          <Comment>ClinVar contains an entry for this variant (Variation ID: 420018). This variant is also known as c.419_422delTCTT (p.Ile140Serfs*10). This premature translational stop signal has been observed in individual(s) with pyridoxine-dependent epilepsy (PMID: 19142996). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Ile168Serfs*10) in the ALDH7A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALDH7A1 are known to be pathogenic (PMID: 16491085, 20554659). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALDH7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.125918554_125918557del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1849508" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1103453" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2397125" TraitType="Disease" MappingType="XRef" MappingValue="C1849508" MappingRef="MedGen">
        <MedGen CUI="C1849508" Name="Pyridoxine-dependent epilepsy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4987354" TraitType="Disease" MappingType="XRef" MappingValue="C1849508" MappingRef="MedGen">
        <MedGen CUI="C1849508" Name="Pyridoxine-dependent epilepsy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3966584" TraitType="Disease" MappingType="XRef" MappingValue="266100" MappingRef="OMIM">
        <MedGen CUI="C1849508" Name="Pyridoxine-dependent epilepsy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7576297" TraitType="Disease" MappingType="XRef" MappingValue="266100" MappingRef="OMIM">
        <MedGen CUI="C1849508" Name="Pyridoxine-dependent epilepsy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

